Ye Hong

Ye Hong, listed as chief executive, appears in our data through filings on Peijia Medical Ltd. - B shares, published by HKEX. Over a trading history stretching from 15 May 2020 to 3 June 2026, the count stands at 37 filings.

Both buying and selling appear: 28 purchases worth €32.8M, against 7 sales worth €1.7M. No amount is published for 2 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2026 to date brings 9 purchases and no sales.

The median purchase comes to €111k. Measured against the company's value, the median purchase equals 0.068% of market capitalisation, across 9 purchases where it is known. 26 out of 26 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. Ninety days after publication, 24 purchases show a median change of -3.5%, with the price up in 38% of them. These figures describe past trades and do not predict future prices.

The latest filing, published on 8 June 2026, reports an open-market purchase of €22k in Peijia Medical Ltd. - B. The median gap between a trade and its publication by HKEX is 4 days. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.